SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 153 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $58,000 | -93.5% | 525,906 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $893,000 | -2.3% | 525,906 | 0.0% | 0.01% | -8.3% |
| Q2 2018 | $914,000 | -1.4% | 525,906 | +3.7% | 0.01% | 0.0% |
| Q1 2018 | $927,000 | -13.7% | 507,106 | +5.2% | 0.01% | +9.1% |
| Q4 2017 | $1,074,000 | -17.2% | 481,900 | +7.7% | 0.01% | -21.4% |
| Q3 2017 | $1,297,000 | +229.2% | 447,500 | +403.9% | 0.01% | +180.0% |
| Q2 2017 | $394,000 | +14.9% | 88,800 | +20.3% | 0.01% | 0.0% |
| Q1 2017 | $343,000 | +419.7% | 73,800 | +570.9% | 0.01% | +400.0% |
| Q4 2016 | $66,000 | -40.5% | 11,000 | -45.5% | 0.00% | -50.0% |
| Q3 2016 | $111,000 | -86.9% | 20,200 | -86.6% | 0.00% | -88.2% |
| Q4 2013 | $850,000 | +111.4% | 151,096 | +71.4% | 0.02% | +88.9% |
| Q3 2013 | $402,000 | – | 88,162 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |